Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive inhaled tobramycin for ventilator-associated pneumonia
NL-OMON40796Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ventilator-associated pneumonia (VAP) comparing Bramitob plus IV antibiotics with Placebo inhalation plus IV antibiotics (2 arms). Primary endpoint: Initial response to treatment. Started Mar 2015; status: recruiting.
02
Drugs
tobramycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NL-OMON40796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40796.